These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18397703)

  • 1. Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.
    Bartel C; Obermüller N; Rummel MJ; Geiger H; Hauser IA
    Clin Nephrol; 2008 Apr; 69(4):285-9. PubMed ID: 18397703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.
    Mutluay R; Aki SZ; Erten Y; Konca C; Yagci M; Barit G; Sindel S
    Clin Nephrol; 2008 Dec; 70(6):527-31. PubMed ID: 19049712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives.
    Aivado M; Schulte K; Henze L; Burger J; Finke J; Haas R
    Semin Oncol; 2002 Aug; 29(4 Suppl 13):19-22. PubMed ID: 12170428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome.
    Seipelt G; Böhme A; Koschmieder S; Hoelzer D
    Ann Hematol; 2001 Mar; 80(3):170-3. PubMed ID: 11320903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of rituximab and bendamustine in treating chronic lymphocytic leukaemia (CLL) in end-stage renal disease (ESRD).
    Shoji J; Lew SQ
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minimal-change glomerulonephritis in chronic lymphocytic leukemia: A clinical case].
    Dzhumabaeva BT; Biryukova LS; Golitsyna EP; Varshavsky VA
    Ter Arkh; 2015; 87(12):85-88. PubMed ID: 26978424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic lymphocytic leukemia accompanied by renal failure].
    Dzhumbaeva BT; Biriukova LS; Gemdzhian EG; Kravchenko SK; Melikian AL; Roshtina LS
    Ter Arkh; 2014; 86(12):37-41. PubMed ID: 25804038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic syndrome associated with chronic lymphocytic leukemia resistant to immunosuppressive drugs: remission obtained by splenectomy.
    Halimi JM; Lavabre-Bertrand T; Beraud JJ; Canaud B
    Clin Nephrol; 1996 Apr; 45(4):273-6. PubMed ID: 8861805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases.
    Barbour SJ; Beaulieu MC; Zalunardo NY; Magil AB
    Nephrol Dial Transplant; 2011 Aug; 26(8):2712-4. PubMed ID: 21633102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bendamustine/Mitoxantrone/Rituximab (BMR): a very effective, well tolerated outpatient chemoimmunotherapy for relapsed and refractory CD20-positive indolent malignancies. Final results of a pilot study.
    Weide R; Pandorf A; Heymanns J; Köppler H
    Leuk Lymphoma; 2004 Dec; 45(12):2445-9. PubMed ID: 15621757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bendamustine in chronic lymphocytic leukemia: the future is combination therapy.
    Friedberg JW
    Leuk Lymphoma; 2009 Sep; 50(9):1399-400. PubMed ID: 19811324
    [No Abstract]   [Full Text] [Related]  

  • 13. Bendamustine mitoxantrone and rituximab (BMR): a new effective regimen for refractory or relapsed indolent lymphomas.
    Weide R; Heymanns J; Gores A; Köppler H
    Leuk Lymphoma; 2002 Feb; 43(2):327-31. PubMed ID: 11999564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranoproliferative glomerulonephritis and acute renal failure in a patient with chronic lymphocytic leukemia: Response to obinutuzumab.
    Jain P; Kanagal-Shamanna R; Wierda W; Ferrajoli A; Keating M; Jain N
    Hematol Oncol Stem Cell Ther; 2017 Sep; 10(3):151-154. PubMed ID: 27352257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
    Quinquenel A; Willekens C; Dupuis J; Royer B; Ysebaert L; De Guibert S; Michallet AS; Feugier P; Guieze R; Levy V; Delmer A
    Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies with bendamustine: enhanced activity in combination with rituximab.
    Rummel MJ; Chow KU; Hoelzer D; Mitrou PS; Weidmann E
    Semin Oncol; 2002 Aug; 29(4 Suppl 13):12-4. PubMed ID: 12170426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular large B-cell lymphoma: successful therapy with bendamustine and rituximab.
    Mleczko A; Franke I; Scheinpflug K; Gollnick H; Leverkus M
    Acta Derm Venereol; 2009; 89(4):425-7. PubMed ID: 19688165
    [No Abstract]   [Full Text] [Related]  

  • 18. [Successful rituximab therapy for MALT lymphoma complicating cryoglobulinemic glomerulonephritis].
    Akiyama K; Itabashi M; Shiohira S; Tsuruta Y; Shimizu A; Kamiyama M; Ishihara M; Otsubo S; Takei T; Taneda S; Honda K; Nitta K
    Nihon Jinzo Gakkai Shi; 2011; 53(5):713-8. PubMed ID: 21842606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas.
    Moulin B; Ronco PM; Mougenot B; Francois A; Fillastre JP; Mignon F
    Kidney Int; 1992 Jul; 42(1):127-35. PubMed ID: 1635342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases.
    Hill PA; Firkin F; Dwyer KM; Lee P; Murphy BF
    Pathology; 2002 Apr; 34(2):138-43. PubMed ID: 12009095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.